0,2520
22-ноября-24 16:44:58
15 мин. задержка
Акции
-0,0040
-1,56%
Сегодняшний диапазон
0,2435 - 0,2684
ISIN
N/A
Источник
NASDAQ
Vincerx Pharma Presents Data on PTEFb/CDK9 Inhibitor VIP152 in DLBCL and CLL at the 63rd American Society of Hematology Annual Meeting
11 дек 2021 15:30:00 Источник Nasdaq GlobeNewswire
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma
07 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire